Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 16/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29562542 | 1.00 | ACHE (0.59) | ACHEKDM4ENPC1S1PR4MAPT | |
| Hydrochloric Acid SCHEMBL668151 | 0.98 | ACHE (0.57) | ACHEKDM4ENPC1S1PR4MAPT | |
| Nitric Acid SCHEMBL29563050 | 0.92 | ACHE (0.55) | ACHEKDM4ENPC1S1PR4MAPT | |
| SCHEMBL3972008 | 0.87 | ACHE (0.74) | ACHE | |
| SCHEMBL29411838 | 0.87 | ACHE (0.74) | ACHE | |
| SCHEMBL4670865 | 0.79 | MAPT (0.39) | ACHEKDM4ENPC1S1PR4MAPT | |
| SCHEMBL7091234 | 0.78 | ALDH1A1 (0.57) | ACHEKDM4ENPC1S1PR4MAPT | |
| SCHEMBL19329417 | 0.75 | ATM (0.50) | ACHEKDM4ENPC1S1PR4MAPT | |
| SCHEMBL2315874 | 0.75 | ATM (0.50) | ACHEKDM4ENPC1S1PR4MAPT | |
| SCHEMBL6904073 | 0.74 | ACHE (1.00) | ACHERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6875 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260133184-A1 | OXIDASE-BASED CHEMILUMINESCENCE ASSAY OF PHAGOCYTIC LEUKOCYTES IN WHOLE BLOOD AND BODY FLUIDS APPLICABLE TO POINT-OF-CARE (POC) DIAGNOSTIC TESTING POINT-OF-CARE (POC) MEASUREMENT OF ABSOLUTE NEUTROPHIL FUNCTION (ANF) | BINARY LLC (US) | 2026-05-14 | — | — | US | claimed |
| US-20260110698-A1 | METHODS FOR QUANTIFYING FRATAXIN ACTIVITY | LARIMAR THERAPEUTICS INC (US) | 2026-04-23 | — | — | US | claimed |
| US-20260063624-A1 | OXIDASE-BASED CHEMILUMINESCENCE ASSAY OF PHAGOCYTIC LEUKOCYTES IN WHOLE BLOOD AND BODY FLUIDS APPLICABLE TO POINT-OF-CARE (POC) DIAGNOSTIC TESTING POINT-OF-CARE (POC) MEASUREMENT OF ABSOLUTE NEUTROPHIL FUNCTION (ANF) | BINARY LLC (US) | 2026-03-05 | — | — | US | claimed |
| US-20250326856-A1 | HUMANIZED ANTI-CD45 ANTIBODIES AND USES THEREOF | Fred Hutchison Cancer Center (US) | 2025-10-23 | — | — | US | claimed |
| EP-4614145-A2 | OXIDASE-BASED CHEMILUMINESCENCE ASSAY OF PHAGOCYTIC LEUKOCYTES IN WHOLE BLOOD AND BODY FLUIDS APPLICABLE TO POINT-OF-CARE (POC) DIAGNOSTIC TESTING POINT-OF-CARE (POC) MEASUREMENT OF ABSOLUTE NEUTROPHIL FUNCTION (ANF) | Binary LLC (US) | 2025-09-10 | — | — | EP | claimed |
| US-12411145-B2 | Methods for quantifying frataxin activity | LARIMAR THERAPEUTICS, INC. (US) | 2025-09-09 | — | — | US | claimed |
| EP-3990900-B1 | OXIDASE-BASED CHEMILUMINESCENCE ASSAY OF NEUTROPHIL LEUKOCYTES IN WHOLE BLOOD APPLICABLE TO POINT-OF-CARE (POC) MEASUREMENT OF ABSOLUTE NEUTROPHIL FUNCTION (ANF) | BINARY LLC (US) | 2025-08-20 | — | — | EP | claimed |
| US-12379379-B2 | Assay | NEOGEN FOOD SAFETY US HOLDCO CORPORATION (US) | 2025-08-05 | — | — | US | claimed |
| US-20250216408-A1 | REAGENT COMBINATION AND METHOD FOR DETECTING TARGET IMMUNOSUPPRESSANT IN WHOLE BLOOD WITHOUT CENTRIFUGATION | SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD. (CN) | 2025-07-03 | — | — | US | claimed |
| EP-4579238-A1 | REAGENT COMBINATION AND METHOD FOR DETECTING TARGET IMMUNOSUPPRESSANT IN WHOLE BLOOD WITHOUT CENTRIFUGATION | Shenzhen New Industries Biomedical Engineering Co., Ltd. (CN) | 2025-07-02 | — | — | EP | claimed |
| EP-0170652-A4 | ASSAY FOR IMMOBILIZED REPORTER GROUPS. | MOLECULAR BIOSYSTEMS INC (US) | 1988-08-23 | — | — | EP | claimed |
| US-4737455-A | CHEMILUMINESCENCE | 501 N.V. Innogenetics (BE) | 1988-04-12 | — | — | US | claimed |
| US-4604364-A | PHOTOPROTEINS, ANTIGEN OR ANTIBODY LIGANDS, GLUTARALDEHYDE COUPLER; NONRADIOACTIVE | KOSAK KENNETH M | 1986-08-05 | — | — | US | claimed |
| EP-0170652-A1 | ASSAY FOR IMMOBILIZED REPORTER GROUPS | MOLECULAR BIOSYSTEMS, INC. (US) | 1986-02-12 | — | — | EP | claimed |
| EP-0159653-A1 | Analytical utilisation of phagocyte cell lines | Innogenetics N.V. (BE) | 1985-10-30 | — | — | EP | claimed |
| WO-1985003356-A1 | ASSAY FOR IMMOBILIZED REPORTER GROUPS | MOLECULAR BIOSYSTEMS, INC. (US) | 1985-08-01 | — | — | WO | claimed |
| EP-0134707-A2 | Method of assaying the activity of cells | TORAY INDUSTRIES, INC. (JP) | 1985-03-20 | — | — | EP | claimed |
| US-4390274-A | Use of a method, particularly an automatic method, for measuring light as well as improvements and apparatuses for carrying out the same | MINNESOTA MINING AND MANUFACTURING COMPANY, A CORP OF DE. | 1983-06-28 | — | — | US | claimed |
| US-4181650-A | Procedure for the assay of pharmacologically immunologically and biochemically active compounds in biological fluids | MAIER CHARLES L JR | 1980-01-01 | — | — | US | claimed |
| US-4104029-A | CHEMILUMINESCENT LABELING | MAIER JR CHARLES L | 1978-08-01 | — | — | US | claimed |